Nang Kuang Pharmaceutical Co., Ltd. (1752) Stock Price & Analysis
1752 Stock Chart & Stats
- Day’s Range
- TWD 28.95 - TWD 30.60
- 52-Week Range
- TWD 28.95 - TWD 39.25
- Previous Close
- TWD 29.55
- Volume
- N/A
- Average Volume (3M)
- 90.77K
- Market Cap
- TWD 3.01B
- Enterprise Value
- TWD 3.69B
- Total Cash (Recent Filing)
- TWD 383.56M
- Total Debt (Recent Filing)
- TWD 684.64M
- Price to Earnings (P/E)
- 14.7
- Beta
- 0.29
- Next Earnings
- Feb 25, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 02, 2026
- Dividend Yield
- 5.37%
1752 FAQ
What was Nang Kuang Pharmaceutical Co., Ltd.’s price range in the past 12 months?
What is Nang Kuang Pharmaceutical Co., Ltd.’s market cap?
When is Nang Kuang Pharmaceutical Co., Ltd.’s upcoming earnings report date?
How were Nang Kuang Pharmaceutical Co., Ltd.’s earnings last quarter?
Is Nang Kuang Pharmaceutical Co., Ltd. overvalued?
Does Nang Kuang Pharmaceutical Co., Ltd. pay dividends?
What is Nang Kuang Pharmaceutical Co., Ltd.’s EPS estimate?
How many shares outstanding does Nang Kuang Pharmaceutical Co., Ltd. have?
What happened to Nang Kuang Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Nang Kuang Pharmaceutical Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nang Kuang Pharmaceutical Co., Ltd.
Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a pharmaceutical enterprise. Its comprehensive product range includes various sterile injectable forms such as parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed intravenous (IV) infusion bags. Additionally, it manufactures conventional dosage forms like tablets, capsules, oral suspensions, and topical applications. The company's offerings span a wide array of therapeutic categories, including treatments for cardiovascular, gastrointestinal, and nervous system disorders; alimentary and metabolic conditions; blood-related issues; antineoplastic and immunomodulatory agents; musculoskeletal and respiratory ailments; dermatological concerns; genito-urinary and sex hormone therapies; systemic hormones; and systemic antibacterials. Nang Kuang also supplies cosmetic products and comprehensive hospital solutions. Furthermore, Nang Kuang specializes in advanced pharmaceutical technologies, producing sterile and anticancer injectable products, controlled-release formulations (both injectable and oral), and oral disintegrating tablets. Founded in 1963, Nang Kuang Pharmaceutical Co., Ltd. is headquartered in Tainan City, Taiwan.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Yu-Bei Wang
- Employees
- 552
- Website
- www.nangkuang.com.tw
- Address
- No. 1001, Zhongshan Road, Tainan City, TQ, 71243, TW
Nang Kuang Pharmaceutical Co., Ltd. (1752) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 13 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 1 | 0 | 11 |

